Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient
PROTEOMICS · 2024
DOI: 10.1002/pmic.202300644 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2024. Verfasst von Samantha J Emery-Corbin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Technology and Biology Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Proteome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Thermal proteome profiling (TPP) is a powerful tool for drug target deconvolution. Recently, data‐independent acquisition mass spectrometry (DIA‐MS) approaches have demonstrated significant improvements to depth and missingness in proteome data, but traditional TPP (a.k.a. CEllular Thermal Shift Assay “CETSA”) workflows typically employ multiplexing reagents reliant on data‐dependent acquisition (DDA). Herein, we introduce a new experimental design for the Proteome Integral Solubility Alteration via label‐free DIA approach (PISA‐DIA). We highlight the proteome coverage and sensitivity achieved by using multiple overlapping thermal gradients alongside DIA‐MS, which maximizes efficiencies in PISA sample concatenation and safeguards against missing protein targets that exist at high melting temperatures. We demonstrate our extended PISA‐DIA design has superior proteome coverage as compared to using tandem‐mass tags (TMT) necessitating DDA‐MS analysis. Importantly, we demonstrate our PISA‐DIA approach has the quantitative and statistical rigor using A‐1331852, a specific inhibitor of BCL‐xL. Due to the high melt temperature of this protein target, we utilized our extended multiple gradient PISA‐DIA workflow to identify BCL‐xL. We assert our novel overlapping gradient PISA‐DIA‐MS approach is ideal for unbiased drug target deconvolution, spanning a large temperature range whilst minimizing target dropout between gradients, increasing the likelihood of resolving the protein targets of novel compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Technology and Biology Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.
- ACRF Chemical Biology Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- Blood Cells and Blood Cancer Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
- Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Victoria, Australia.
- Infection and Immunity Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
ORCID-Profile: Samantha J Emery-Corbin, Laura F Dagley
Zitieren
APA
Emery-Corbin, S. J., Yousef, J. M., Adhikari, S., Sumardy, F., Nhu, D., van Delft, M. F., Lessene, G., Dziekan, J., Webb, A. I., & Dagley, L. F. (2024). Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient. PROTEOMICS. https://doi.org/10.1002/pmic.202300644
Vancouver
Emery-Corbin SJ, Yousef JM, Adhikari S, Sumardy F, Nhu D, van Delft MF, et al. Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient. PROTEOMICS. 2024. doi:10.1002/pmic.202300644
BibTeX
@article{EmeryCorbin2024,
author = {Emery-Corbin, Samantha J and Yousef, Jumana M and Adhikari, Subash and Sumardy, Fransisca and Nhu, Duong and van Delft, Mark F and Lessene, Guillaume and Dziekan, Jerzy and Webb, Andrew I and Dagley, Laura F},
title = {Improved drug target deconvolution with PISA‐DIA using an extended, overlapping temperature gradient},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202300644}
}
EUVIMED